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Abstract
The design and application of biomimetic hydrogels have become an important and integral part 
of modern tissue engineering and regenerative medicine. Many of these hydrogels are prepared 
from synthetic macromers (e.g., poly(ethylene glycol) or PEG) as they provide high degrees of 
tunability for matrix crosslinking, degradation, and modification. For a hydrogel to be considered 
biomimetic, it has to recapitulate key features that are found in the native extracellular matrix, 
such as the appropriate matrix mechanics and permeability, the ability to sequester and deliver 
drugs, proteins, and or nucleic acids, as well as the ability to provide receptor-mediated cell-matrix 
interactions and protease-mediated matrix cleavage. A variety of chemistries have been employed 
to impart these biomimetic features into hydrogel crosslinking. These chemistries, such as radical-
mediated polymerizations, enzyme-mediated crosslinking, bio-orthogonal click reactions, and 
supramolecular assembly, may be different in their crosslinking mechanisms but are required to be 
efficient for gel crosslinking and ligand bioconjugation under aqueous reaction conditions. The 
prepared biomimetic hydrogels should display a diverse array of functionalities and should also be 
cytocompatible for in vitro cell culture and/or in situ cell encapsulation. The focus of this article is 
to review recent progress in the crosslinking chemistries of biomimetic hydrogels with a special 
emphasis on hydrogels crosslinked from poly(ethylene glycol)-based macromers.
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Introduction
Biomimetic hydrogels are a class of water-imbibing but insoluble polymer networks that 
present aspects of native extracellular matrix (ECM) to the surrounding or encapsulated 
cells. These aspects include the ability to emulate native matrix mechanics, sequester and 
deliver growth factors, as well as provide cell-matrix interactions such as ligand-receptor 
binding and protease-medicated matrix cleavage.[1–4] To mimic matrix mechanics, one can 
simply adjust the degree of network crosslinking of a hydrogel.[5–11] Growth factor 
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sequestration is often achieved by the covalent immobilization of ‘affinity ligands’ (e.g., 
heparin, affinity peptides, small molecular weight ligands, and aptamers) in the 
network.[2, 12–17] The presentation of receptor-binding ligands (e.g., Arg-Gly-Asp peptide, 
often as network-immobilized pendent motifs) induces receptor-mediated intracellular 
signaling that is important for maintaining or guiding cell viability and function.[3, 18, 19] 
Furthermore, the presence of protease-sensitive substrates (e.g. matrix metalloproteinases 
(MMPs) cleavable peptides, often serve as a gel crosslinker) permits cell-mediated local 
matrix cleavage and subsequent cell fate processes, which include migration, extension of 
cellular processes, and proliferation.[4, 20, 21] It is known that matrix mechanics profoundly 
affect cell fate processes through regulating intracellular tensions.[22–24] Emerging work has 
also demonstrated that along with matrix degradation, the mechanics of the matrix influence 
cell spreading and cell fate determination.[25–27] Hydrogels are ideal matrices for this type of 
study as the mechanical properties of these water-swollen matrices can be easily and 
sometimes independently tuned to mimic native tissue elasticity and bio-functionality.[28] 
The overarching goal of creating biomimetic hydrogels is to recapitulate local cell-matrix 
interactions for improving the outcome of global tissue regeneration and/or to understand 
fundamental mechanisms by which specific extracellular signals influence cell fate 
determination.
In the past few decades, significant efforts have been dedicated to the design and synthesis 
of biomimetic hydrogels for tissue engineering and regeneration medicine 
applications.[1, 3, 4, 29] Many of these hydrogels are fabricated to present soluble or 
immobilized proteins/peptides as well as controllable matrix elasticity to cells that are 
encapsulated within or adhered onto the biomimetic hydrogels. Biomimetic hydrogels can 
be tailored to allow both two-dimensional (2D) and three-dimensional (3D) cell cultures.[30] 
Compared with flat, rigid, and 2D tissue culture polystyrene (TCPS) or animal-based 3D 
matrices (e.g., Matrigel or collagen gel), biomimetic hydrogels composed of synthetic 
polymers, such as poly(ethylene glycol) or PEG, are more flexible and have tunable material 
properties. Notable applications of biomimetic hydrogels include preservation and 
differentiation of stem/progenitor cells, exploration of tumor cell migration, invasion, drug 
responsiveness, and epithelial-mesenchymal transition (EMT), as well as tissue/organ 
regeneration. The goal of this article is to review some important hydrogel crosslinking 
chemistries and to provide an update on recent advances in the fabrication of PEG-based 
biomimetic hydrogels.
Functionalization of PEG-based biomimetic hydrogels using 
photopolymerizations
Chain-growth photopolymerizations
PEG-based hydrogels possess tissue-like elasticity, high water content, solute permeability, 
cytocompatibility, and biocompatibility.[1, 31] These preferential properties have rendered 
PEG-based hydrogels highly useful in a variety of biomedical applications, including the 
controlled release of therapeutically relevant agents and the encapsulation and delivery of 
cells for immuno-isolation or cell-based therapy.[32] Since the chemical makeup of PEG (-
(CH2CH2O)n-) contains no biological recognition site, modification of PEG-based hydrogels 
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is required to render the otherwise inert network biomimetic and cell-responsive.[33] One 
classic example of functionalizing PEG hydrogels is through co-polymerization of 
functionalized (e.g., acrylated or methacrylated) peptides during the network cross-
linking.[18, 34, 35] Propagation of radicals (generated from a cleavage type photoinitiator) on 
vinyl groups results in simultaneous network crosslinking and peptide immobilization 
(Figure 1A). Acrylated or methacrylate peptides (Figure 1B) can be easily co-polymerized 
within PEG-diacrylate (PEGDA) or PEG-dimethacrylate (PEGDMA) hydrogels through 
chain-growth homo-polymerization. Hern and Hubbell used N-hydroxysuccinimidyl (NHS)-
activated esters (attached either directly to acrylic acid or with a PEG spacer) to introduce an 
acrylate moiety to the N-terminal α-amine of the peptide.[18] These acrylated peptides can 
be co-polymerized with PEGDA to form cell-adhesive or bioactive PEG hydrogels. This 
approach will continue to be an important method of functionalizing PEG hydrogels due to 
its simplicity. However, two caveats of this approach are as follows: (1) the pendent 
peptides are co-polymerized within hydrophobic poly(acrylate) or poly(methacrylate) 
kinetic chains and may have decreased accessibility to the co-encapsulated cells and (2) the 
immobilization efficiencies of (meth)acrylate-based pendent peptides are generally low 
(~60%)[19, 36] and the sol fraction of the bioactive peptides may cause undesired biological 
responses in the co-encapsulated cells.
The co-polymerization of pendent peptides within PEG hydrogels provides binding sites in 
the gels for cell surface receptor activation. To render PEG-based hydrogels truly cell 
responsive, protease sensitivity must also be integrated in the design of a biomimetic 
hydrogel. PEG hydrogels crosslinked from PEGDA or PEGDMA are hydrolytically and 
proteolytically stable on therapeutically relevant time scales. To render the covalently 
crosslinked PEG hydrogels degradable, segments of degradable motifs can be incorporated 
in the macromer backbone.[32, 37] For example, the polymerization of acrylated PLA-PEG-
PLA macromers yields hydrolytically degradable hydrogels with predictable gel degradation 
rates.[32, 38, 39] Protease responsiveness can be integrated into PEG-based hydrogels through 
crosslinking with known peptide substrates for selective proteases. For example, hetero-
bifunctional PEG macromers such as acrylate-PEG-NHS were used to react with MMP-
sensitive peptides (e.g., NH2-GPQG↓IWGQK) through nucleophilic addition to primary 
amines, thus producing a homopolymerizable PEG macromer with protease sensitivity 
(Figure 1C).[40] Cells encapsulated within this type of hydrogel network were able to 
remodel their local matrix through protease secretion. While the protease sensitivity of this 
type of chain-growth PEG hydrogel can be tuned by adjusting the amount of protease 
sensitive macromer (i.e., acryl-peptide-PEG-peptide-acryl) added during network 
crosslinking, the accessibility of protease sensitive sections of the macromer to the co-
encapsulated cells might be limited because of the presence of poly(acrylate) kinetic chains 
following crosslinking. Another limitation of this system is that the NHS on acrylate-PEG-
NHS might react with bioactive lysine residues that are present within the protease sensitive 
sequence.
Step-growth photopolymerizations
PEG-based hydrogels can be prepared by step-growth photopolymerization (Figure 2A), 
which yields gels with more homogeneous network structures and better mechanical 
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properties compared to chain-growth polymerized gels with similar macromer 
content.[41, 42] The use of photopolymerization permits not only rapid gelation (gel points 
within seconds), but also spatial-temporal control over gelation kinetics. The crosslinking of 
PEG-based step-growth hydrogels requires the use of macromers with an average 
functionality of greater than two.[43, 44] Anseth and colleagues developed a radical-mediated 
and step-growth photopolymerization scheme, termed thiol-norbornene 
photopolymerization, for forming biomimetic step-growth PEG hydrogels.[45] A multi-arm 
PEG macromer functionalized with norbornene was used to react orthogonally with thiol-
containing bi-functional peptides via long wavelength ultraviolet (UV) light mediated step-
growth photopolymerization and to form hydrogels. The peptide crosslinker contains a 
sequence that can be cleaved by MMPs and is flanked by terminal cysteine residues (e.g., 
CGPQG↓IWGQC). The additional cysteines permit a radical-mediated thiol-norbornene 
‘photo-click’ reaction, while the presence of the MMP-sensitive sequence allows cell-
mediated network cleavage to accommodate cellular processes such as migration, 
proliferation, and differentiation.[46–48] Other bioactive motifs (e.g., cell adhesive ligands 
RGDS) can be incorporated within these hydrogels through the conjugation of mono-
cysteine peptides during network crosslinking. The incorporation of pendent bioactive 
motifs can be easily achieved using peptides bearing a cysteine residue (Figure 2B). 
Compared to chain-growth acrylate homopolymerizations, step-growth thiol-norbornene 
gelation has been shown to exhibit better cytocompatibility for radical sensitive cells such as 
pancreatic β-cells[41] and chondrocytes.[49] In addition to UV light mediated cross-linking, 
our own group has developed a visible light (400–700 nm) mediated thiol-norbornene 
photo-crosslinking method aided by a non-cleavage type photosensitizer eosin-Y.[50–52] 
Upon visible light exposure, excited eosin-Y molecules deprotonate thiols to give thiyl 
radicals that subsequently initiate thiol-norbornene reactions to produce step-growth 
hydrogels with protease sensitivity and cell adhesive properties. The use of visible light 
eliminates the concerns that UV light, even at long wavelengths and low intensity, could 
induce cellular damage with biological complications. Readers are directed to a recent 
review that summarizes the progress of thiol-norbornene hydrogels to-date.[53]
Mixed-mode photopolymerizations
Acrylated PEGs (i.e., linear PEGDA or multi-arm PEG-acrylates) are a unique class of 
macromer as they can be crosslinked into chain-growth hydrogels (through 
homopolymerization of PEG-acrylates),[18] step-growth hydrogels (by reacting with thiol-
containing crosslinkers via nucleophilic conjugation addition reaction),[44] or mixed-mode 
networks (through radical mediated thiol-acrylate polymerization).[54] Peptides or proteins 
with one or more sulfhydryl groups can also be covalently incorporated in PEG hydrogels 
through a mixed-mode photopolymerization.[54] Figure 3 shows the mechanism of mixed-
mode thiol-acrylate polymerization and the incorporation of biomolecules such as peptides. 
When a higher concentration of thiol is used, the polymerization shifts toward step-growth 
polymerization.[55] Bioactive peptides, either incorporated as pendant ligands or as part of 
the crosslinkers, can be easily incorporated as long as cysteine residues are incorporated into 
the peptide sequences during peptide synthesis. Peptides with additional spacers inserted 
between the cysteine and bioactive motifs can be used to increase the accessibility of the 
immobilized peptides to soluble proteins [12, 16] or to enhance mesenchymal stem cell 
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viability in PEG hydrogels.[54] This class of hydrogels can be prepared via either long-wave 
UV light (365 nm)[56] or visible light (400–700 nm)[57] initiation as long as an appropriate 
initiator is used (e.g., type-1 initiator for UV-mediated crosslinking and type-2 initiator for 
visible light-mediated crosslinking). It can be noted that mixed-mode hydrogels polymerized 
from acrylated/methacrylated macromers and thiol-containing crosslinkers contain 
hydrolytically labile thioether ester bonds.[36, 58] Hydrolysis of these ester bonds may not 
only facilitate cell spreading and viability but may also lead to early disintegration of the gel 
network. Moreover, the immobilization efficiency of acrylated peptides (~60%) has been 
shown to be lower than that of thiolated peptides (~80–90%).[58]
Enzyme-mediated crosslinking of biomimetic hydrogels
Several enzymes have been employed for fabricating hydrogels in biomedical applications. 
For example, horseradish peroxidase (HRP) catalyzes the formation of carbon-carbon bond 
or carbon-oxygen bond in substrates, such as phenols or anilines, in the presence of 
hydrogen peroxide (H2O2). Similarly, glucose oxidase (GOX), when mixed with glucose 
and dissolved oxygen, generates gluconolactone and H2O2 that is further reduced into 
hydroxyl ions (OH−) and hydroxyl radicals (•OH) in the presence of ferrous ions (Fe2+). 
When sufficient vinyl monomers are present in the solution, hydroxyl radicals initiate chain-
growth polymerization to form a covalently crosslinked hydrogel.[59–61] Except for a few 
examples,[62, 63] the cyto- and bio-compatibility of hydrogels crosslinked by HRP or GOX is 
adversely affected due to the requirement for (in the case of HRP) or generation of (in the 
case of GOX) H2O2. While past efforts have demonstrated the unique biomedical 
applications of PEG-based hydrogels crosslinked by enzymatic activity of HRP or GOX, the 
use of these enzymes to prepare biomimetic hydrogels that have both cell adhesiveness and 
protease sensitivity has attracted less attention.
Thrombin is a critical enzyme in the coagulation cascade. In the presence of factor XIIIa, an 
activated transglutaminase, thrombin converts soluble fibrinogen into an insoluble fibrin 
clot. Factor XIIIa catalyzes an acyl-transfer reaction between the γ-carboxamide group of 
protein bound glutaminyl residues and the amino group of lysine residues to form covalent 
isopeptide bridges. Lutolf et al. harnessed this efficient reaction and developed biomimetic 
hydrogels capable of being degraded by enzymatic reactions (Figure 4).[64] In particular, 
factor XIIIa was utilized to simultaneously cross-link peptide-functionalized PEG and 
incorporate bioactive peptides. The fusion peptides used contained substrates for factor 
XIIIa and MMP (e.g., Ac-FKGG-GPQGIWGQ-ERCG-NH2 and H-NQEQVSPL-ERCG-
NH2). Some sequences also contained the cell adhesive ligand such as H-NQEQVSPL-
RGDSPG-NH2. Among these peptides, the sequence NQEQVSPL was derived from the N-
terminus of α2-plasmin inhibitor (α2PI1–8), whereas the sequence Ac-FKGG was optimized 
for rapid transglutaminase reaction.[65] Upon the addition of factor XIIIa and Ca2+, the two 
segments containing Lys and Gln residues (i.e., Ac-FKGG and NQEQVSPL, respectively) 
were catalytically incorporated into a covalent linkage that either has MMP sensitivity (from 
sequence GPQGIWGQ) or cell adhesiveness (from sequence RGDS). Depending on the gel 
formulations and enzyme concentrations, the gelation could occur within several minutes 
and the resulting gels supported spreading, proliferation, and migration of human dermal 
fibroblasts. Hydrogels crosslinked by factor XIIIa-mediated enzymatic reactions have been 
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used in a variety of functional tissue engineering applications. For instance, diverse 3D 
peptide (e.g., RGD) or protein (e.g., fibrin, VEGF, or PDGF) patterns could be created 
within PEG-based hydrogels through selective light-activated enzymatic reactions.[66] 
hMSCs encapsulated within these dynamically patterned hydrogels showed pattern shape-
guided invasion[66] and pattern gradient-induced morphogenesis.[67]
Tyrosinase, an enzyme that oxidizes phenols, is another useful enzyme for the crosslinking 
of hydrogels and underwater bioadhesives.[68] For example, Messersmith and colleagues 
synthesized 3,4-dihydroxyphenylalanine (DOPA)-modified PEGs,[69] which were cross-
linked into hydrogels in the presence of tyrosinase (Figure 5). In another example, Park et 
al. prepared tyramine-functionalized Pluronic F-127 tri-block copolymers, which were 
utilized to form self-assembled micelles.[70] The tyramine-conjugated micelles were 
converted to highly reactive catechol conjugated micelles by tyrosinase. Stable hydrogels 
were formed due to the cross-linking of Pluronic copolymer micelles. Although these 
hydrogels did not contain peptide linkers sensitive to cell-secreted proteases or cell adhesion 
ligands, it will be possible to create such biomimetic matrices using macromers pre-
conjugated with cell adhesive and/or protease sensitive peptides.
Click hydrogels as biomimetic matrices
‘Click’ chemistry is used to describe highly efficient, quantitative, and orthogonal reactions 
between mutually reactive functional groups and it has been used to create functional 
polymers and network hydrogels for biomedical applications.[71, 72] For example, Hubbell 
and colleagues pioneered the development of PEG-based click hydrogels. They incorporated 
elegant MMP-sensitive peptide sequences in the hydrogels using nucleophilic Michael-type 
addition reactions between multi-arm PEG-vinylsulfone and MMP-sensitive peptide 
crosslinkers with terminal cysteines.[20] Cell adhesive ligands could be easily conjugated 
using the same Michael-type addition chemistry. Methacrylate, acrylate, and maleimide can 
also be used to react with bis-cysteine peptides (or multifunctional thiol macromers) for 
forming cell responsive hydrogels. The major benefit of biomimetic hydrogels formed by 
nucleophilic conjugation addition reactions is that it does not involve the generation of 
radicals, which poses major cytocompatibility concerns for radical-sensitive cells. Some of 
the other notable click chemistries useful in creating biomimetic hydrogels include native 
chemical ligation,[69, 73] oxime-ligand,[74] azide-alkyne addition,[75–78] Diels-Alder 
reaction,[79] and tetrazine chemistry.[80, 81] Similar to the Michael-type conjugation reaction, 
these chemoselective chemistries are not light dependent and do not require initiators to 
initiate gel crosslinking. In general, this gelation chemistry lacks spatial-temporal control in 
gelation kinetics. Furthermore, the reaction rates may be slow at neutral pH values.
The cross-linking chemistries discussed above have been highly useful for creating 
biomimetic hydrogels for 3D cell studies. However, most of these chemistries do not permit 
the dynamic modification of biophysical or biochemical gel properties. The ability to 
dynamically control gel properties is especially important if one considers that stem and 
progenitor cells receive complex and dynamic extracellular signals during morphogenesis. 
Pathological processes in many diseases are also induced by the deregulation of biological 
signals. It has become increasingly evident that biomaterials capable of mimicking dynamic 
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changes of biological cues are powerful tools for studying tissue regeneration. Significant 
efforts have been dedicated to formulating such dynamic matrices. For example, Shoichet et 
al. incorporated a nitrobenzyl-protected cysteine in agarose hydrogels to guide 3D cell 
growth and migration.[82, 83] Upon UV exposure, the nitrobenzyl group is removed, 
revealing the free sulfhydryl group for additional thiol-maleimide conjugation. 
Biomolecules can be patterned in 3D to guide cell migration in a spatial-temporally 
regulated manner.
It will be beneficial if the modification of hydrogel properties can be performed in the 
presence of cells. For example, Fairbanks et al. developed step-growth thiol-norbornene 
hydrogels that were crosslinked with an excess amount of norbornene functionalities during 
network crosslinking.[45] Due to the lack of homopolymerization between norbornene 
groups and the step-growth nature of the thiol-norbornene reaction, additional thiol-bearing 
molecules can be patterned within the gel network in the presence of cells. In addition to 
immobilizing pendant ligands in the presence of cells, one may wish to ‘exchange’ the 
ligands to truly recapitulate a dynamic developmental process during tissue morphogenesis. 
In this regard, an addition-fragmentation-chain transfer reaction was developed to allow 
controlled and reversible exchange of biochemical ligands within an allyl sulfide 
functionalized PEG hydrogel (Figure 6).[84]
Significant achievements have been made in using orthogonal ‘click’ chemistry to 
synthesize biomimetic and dynamically tunable hydrogels. Anseth and colleagues created 
photolabile hydrogels by incorporating nitrobenzyl groups to the PEG or peptide 
crosslinkers.[85–87] Hydrogels were firstly formed via the redox crosslinking and the gel 
crosslinking density was decreased in a spatial-temporally controlled manner by adjusting 
the dosage and location of UV light exposure. When the photolabile group was incorporated 
on pendant peptides, UV light exposure caused the liberation of these peptides. The system 
is cytocompatible and the modification of hydrogel properties could be performed in the 
presence of cells.
Dynamically tunable hydrogels can be prepared by copper-catalyzed azide-alkyne Huisgen 
cycloaddition reactions (CuAAC). Anseth et al. used this chemistry to fabricate PEG-based 
hydrogels with patternability.[88] Unfortunately, this reaction is not suitable for in situ cell 
encapsulation due to the cytotoxicity of copper ions. Furthermore, they developed an 
alternative approach wherein cyclooctyne, a macromer synthesized originally by the 
Bertozzi group,[89] was used to react with azides free of cytotoxic metal ions.[76] The metal-
free and orthogonal reactivity between a strained cyclooctyne and an azide has allowed 
researchers to design multifunctional macromers that can be cleaved by cell-secreted 
proteases and for spatial-temporally controlled conjugation of bioactive motifs. For 
example, DeForest and Anseth designed a ‘sequential-click’ approach in a step-growth 
network to allow the formation of a hydrogel network and modification of its properties 
through orthogonal conjugation and cleavage of biomimetic peptides.[76–78, 90] To expand 
the utility of dynamic patterning of bioactive motifs in 3D, DeForest and Tirrell recently 
reported the conjugation and removal of the whole protein within the orthogonally 
crosslinked network.[91] Two bioorthogonal photochemistries, oxime ligation (Figure 7A) 
and ortho-nitrobenzyl ester photoscission (Figure 7B), were employed to permit user-
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defined spatial-temporal photo-patterning and removal of whole proteins (Figure 7C). The 
Anseth group has expanded the toolkits of bio-orthogonal click hydrogels to include: (1) 
tetrazine-norbornene click reaction (Figure 8A)[80] and (2) ligation between aliphatic 
hydrazine with a benzaldehyde- or an aliphatic-aldehyde (Figure 8B).[92] The hydrazine-
aldehyde click reaction is particularly intriguing as it results in a covalently adaptable 
network that can respond to cell-induced stress through breaking/reforming elastically active 
crosslinks while maintaining a macroscopically stable material.
Hydrogels formed from supramolecular assembly
In addition to the aforementioned covalent crosslinking strategies, PEG-based biomimetic 
hydrogels can be prepared through macromolecular or supramolecular self-assembly. 
Macromolecular/supramolecular assembled hydrogels are favorable in many applications 
because gelation is induced by a purely physical process, which does not rely on radical 
species.[93] However, compared with covalently crosslinked hydrogels, these gels can have 
weaker mechanical properties due to the instability of the physical interactions between 
macromolecules. The most commonly used functionality in macromolecules suitable for 
forming self-assembled hydrogels are amphiphilic cyclodextrins (CD), including α-CD, β-
CD, and γ-CD, which are composed of 6, 7, and 8 cyclic saccharides, respectively.[94, 95] 
The inner hydrophobic cavity of CDs affords physical interactions with hydrophobic 
molecules, while the hydrophilic outer surface facilitates the dissolution of the molecules in 
an aqueous environment. The hydroxyl groups on CDs provide handles for facile chemical 
modifications, which expand the utility of CDs in biomaterials, drug delivery, and tissue 
engineering applications.
Supramolecular polymers are increasingly being used as ‘building blocks’ to fabricate 
diverse 3D crosslinked polymer networks. For example, macrocyclic CDs and 
cucurbit[n]urils are routinely used with specific ‘guest’ molecules to form poly-rotaxanes or 
catenanes. In particular, CD forms inclusion complexes with hydrophobic guest molecules 
such as adamantane, azobenzene, ferrocene, and stilbene.[93] In one example, Burdick and 
colleagues harnessed inclusion complex formation between CD and adamantane (Ad), 
which were separately conjugated to hyaluronic acid (HA), to prepare shear-thinning 
hydrogels for tissue engineering applications.[96–98] The inclusion complexes formed 
between CD and Ad led to HA hydrogel formation but the complexes disassembled under 
shear force, leading to a gel-sol transition. Upon the removal of shear force, the host-guest 
complexes, and hence the crosslinked hydrogel, re-formed. This new class of 
supramolecular polymer offers high injectability for implanted biomaterials in a minimally 
invasive manner. Similar to CDs that bind to hydrophobic molecules, cucurbit[n]uril (CB) 
binds strongly to guest molecules such as naphthalene and viologen. The complexation 
between CB and naphthyl-/viologen-functionalized polymers has been used to prepare 
protein-loaded hydrogels for controlled release applications.[99–101] The aforementioned 
examples have demonstrated the great utilities of supramolecular assembly in hydrogel 
formation for biomedical applications.
Supramolecular assembly strategies have also been integrated in the design of PEG-based 
biomimetic hydrogels. For example, Elisseeff and colleagues have developed α-CD-
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threaded PEGDA hydrogels for tuning the biophysical and biochemical properties of chain-
growth PEG-based hydrogels.[102] Figure 9 illustrates how supramolecular polymers can 
serve as ‘carriers’ to impart multiple and orthogonal functionalities to a hydrogel network. 
The PEG ‘necklaces’ are decorated/threaded with functionalized αCD to produce hydrogels 
with tunable mechanics (by changing PEGDA concentration), adhesion (by adjusting the 
concentration of functionalized αCD but not PEGDA), or chemistry (by introducing αCD 
with different functional groups, e.g., -CH3 or -PO4−). By manipulating the compositions of 
these supramolecules, multifunctional hydrogels were created for promoting adhesion, 
proliferation, and differentiation of hMSCs[102] or for studying the roles of matrix 
mechanics and functions on cancer cell invasion.[103] While not demonstrated in this 
publication, protease-sensitivity can be integrated into PEG-CD hydrogels by replacing 
PEGDA with diacrylated PEG-peptide macromers (Figure 1C).
The example shown in Figure 9 exploited modified CD as carriers of functional or bioactive 
motifs. The self-assembly between CD and PEG has also been utilized to prepare 
‘pseudopolyrotaxane’ hydrogels. For instance, Cooper-White et al. explored the gelation 
kinetics and viscoelastic properties of such hydrogels formed by assembly of α-CD and 
Pluronic polymers (F68 and F127) without or with micelle formation.[104] The formation of 
‘poly-CDs’ at a concentration of over 40 mM of α-CD (25 °C) is critical in this physical 
gelation/assembly system. The threading of Pluronic polymers into pre-assembled poly-CDs 
leads to gelation (Figure 10A). In the presence of Pluronic micelles, however, the threading 
of poly-CDs onto Pluronic polymer becomes more difficult due to the presence of steric 
hindrance (Figure 10B). The gelation was slower and the gels were weaker in the presence 
of Pluronic micelles. Although these hydrogels could be formed with strong mechanical 
properties (G’ ~106 Pa), they were not stable and dissociated rapidly when immersed in a 
liquid containing no pseudopolyrotaxane complexes. Cooper-White and colleagues recently 
reported an improved design of pseudopolyrotaxane hydrogels in which Pluronic/CD 
assembly was combined with enzyme-mediated crosslinking of tyramine-modified 
PEG.[105] The gelation was facilitated through a horseradish peroxidase (HRP) and 
hydrogen peroxide (H2O2) mediated tyramine oxidation (similar to Figure 5). However, 
careful optimization of enzymatic crosslinking parameters is critical for maintaining 
acceptable cell viability since H2O2 is toxic to cells.
Conclusions
The diversity of biomimetic PEG-based hydrogels has been expanded greatly in recent years 
owing to the discovery/adaptation of bioconjugation chemistries suitable for biomedical 
applications. Past efforts have also demonstrated that a hydrogel matrix with multiple 
functionalities outperforms a single-purpose one for most tissue regeneration applications. 
While no single chemistry is perfect for all applications, one can certainly adopt and 
integrate the available chemistries to create suitable biomimetic matrices for a particular 
tissue regeneration need. It is expected that due to its simplicity, diversity, and proven 
cytocompatibility in many cell types, radical-mediated hydrogel crosslinking (whether 
initiated by UV or visible light) will continue to serve as an indispensable chemistry for the 
design and synthesis of biomimetic hydrogels. The rise of bio-orthogonal chemistry, 
enzyme-mediated crosslinking, and supramolecular chemistries offer great opportunities for 
Lin Page 9
RSC Adv. Author manuscript; available in PMC 2016 January 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
scientists to create complex multifunctional hydrogel matrices for addressing biological 
questions that are otherwise difficult to answer. Lastly, the combination of two or more of 
these diverse chemistries is anticipated to significantly increase the applicability of 
biomimetic hydrogels in tissue engineering and regenerative medicine applications.
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Figure 1. 
(A) Schematic of chain-growth photopolymerization for forming peptide-immobilized 
hydrogels (PI: photopolymerization, hv: light source). (B) Acrylated RGDS peptide for co-
polymerization into PEGDA hydrogels. (C) Schematic of an acrylate-PEG-GPQGIWGQK-
PEG-acrylate crosslinker.
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Figure 2. 
Schematic of step-growth photopolymerization for forming hydrogels (PI: 
photopolymerization, hv: light source). (B) Cysteine-containing RGDS peptide for co-
polymerization into the step-growth hydrogel (N-terminal acetylated peptide).
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Figure 3. 
Schematic of a visible light initiated mixed-mode photopolymerization for forming 
hydrogels (EY: eosin-Y; hv: visible light source; kp,S-C, kp,C=C, kp,CT: kinetic constants for 
thiol-carbon radical propagation, carbon-carbon radical propagation, and chain-transfer, 
respectively.).[36]
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Figure 4. 
Schematic of factor XIIIa-catalyzed formation of a PEG-peptide biomimetic hydrogel. 
Factor XIIIa was used to cross-link two PEG-peptide conjugates (n-PEG-MMP-Lys and n-
PEG-Gln) in combination with a cell adhesion peptide (TG-Gln-RGD) to form 
multifunctional biomimetic hydrogels. Reprinted with permission from [64]. Copyright 2007, 
American Chemical Society.
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Figure 5. 
Oxidative conversion of tyramine to a catechol and subsequent crosslinking by tyrosinase.
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Figure 6. 
Mechanism of addition fragmentation chain transfer of an allyl sulfide functional group 
upon attack by a thiyl radical. Redrawn with permission from [84]. Copyright 2014, John 
Wiley and Sons.
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Figure 7. 
(A) Caged alkoxyamines undergo irreversible β-elimination upon exposure to 365 or 740 nm 
light. The liberated alkoxyamines react with aldehyde-functionalized proteins (R2) to form 
oxime linkages. (B) o-Nitrobenzyl ester (oNB) moieties linking the protein of interest (R1) 
and the hydrogel (R2) undergo photocleavage upon exposure to 365 nm or 740 nm light. (C) 
Schematic of the photo-reversible patterning strategy. NHS-oNB-CHO-functionalized 
proteins are first tethered to the gel through photo-mediated oxime ligation and subsequently 
removed on secondary light exposure. Reprinted with permission from [91]. Copyright 2015, 
Nature Publishing Group.
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Figure 8. 
(A) Tetrazine-norbornene click reaction; (B) covalently adaptable network formed by N-
methyl hydrazine-butyraldehyde ligation.
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Figure 9. 
Schematic of a molecular-necklace system to create multifunctional hydrogels with 
independent control of gel mechanics, cell adhesiveness, and chemical functionality. a) 
Inclusion complex between PEGDA and α-CD (R = hydroxyl or other functional groups). b) 
Tuning the mechanical properties of an α-CD-PEG hydrogel independent of α-CD 
concentration. c) Tuning the concentration of a cell adhesive peptide through threading 
different amount of functionalized α-CD independent of gel cross-linking density. d) Tuning 
the chemical functionality of a hydrogel through threading αCD with different functional 
groups (i.e., hydrophobic, hydrophilic or charged groups). Reprinted with permission 
from [102]. Copyright 2013, John Wiley and Sons.
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Figure 10. 
Temporal gelation mechanism of linear Pluronic (e.g.: F6810 and F6820) or Pluronic 
micelles (e.g.: F12710) and α-CD. (A) Gelation without micelle formation. (B) Gelation in 
the presence of micelles. Reprinted with permission from [104]. Copyright 2013, American 
Chemical Society.
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